CBLL
CeriBell, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders -7.1% ·
aandelenstroom +3.0% ·
netto nieuwe posities -7.7%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 55 | +3 | 18.41M | $358.31M | +6 | −3 |
| Q1 2026 | 54 | +2 | 17.21M | $315.46M | +5 | −3 |
| Q4 2025 | 52 | +2 | 15.60M | $342.15M | +3 | −1 |
| Q3 2025 | 13 | -1 | 10.65M | $122.41M | — | −1 |
| Q2 2025 | 11 | +3 | 9.35M | $175.16M | +4 | −1 |
| Q1 2025 | 5 | -4 | 940.06K | $18.06M | — | −4 |
| Q4 2024 | 9 | +8 | 1.55M | $40.23M | +8 | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 4.48M | -7.4% | $51.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.48M | -7.4% | $51.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.48M | -7.4% | $51.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 4.48M | -7.4% | $51.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 4.48M | -7.4% | $51.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 1.69M | +11.1% | $19.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 1.69M | +11.1% | $19.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 1.69M | +11.1% | $19.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 1.69M | +11.1% | $19.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 1.69M | +11.1% | $19.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 1.69M | +11.1% | $19.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 1.69M | +11.1% | $19.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 1.69M | +11.1% | $19.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 1.47M | +11.1% | $16.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 1.47M | +11.1% | $16.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 1.47M | +11.1% | $16.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 1.47M | +11.1% | $16.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 1.47M | +11.1% | $16.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 822.36K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 822.36K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 822.36K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 822.36K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 822.36K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 822.36K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 822.36K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 822.36K | — | $9.45M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Millennium Management ✦ | 666.45K | +41.8% | $7.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 581.93K | +29.9% | $6.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | Geode Capital Management ✦ (passief) | 581.93K | +29.9% | $6.69M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (passief) | 412.94K | +7.4% | $4.74M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 297.96K | +81.0% | $3.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 154.54K | — | $1.78M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 154.54K | — | $1.78M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 154.54K | — | $1.78M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 154.54K | — | $1.78M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 154.54K | — | $1.78M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 154.54K | — | $1.78M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Morgan Stanley ✦ | 154.54K | — | $1.78M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Morgan Stanley ✦ | 154.54K | — | $1.78M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Marshall Wace ✦ | 46.78K | +6.0% | $537,456 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 41 | T. Rowe Price ✦ | 13.04K | +4.6% | $150,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | Goldman Sachs Group ✦ | 10.59K | — | $121,702 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Point72 Asset Management ✦ | 3.42K | -94.8% | $39,287 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Citadel Advisors | $1.43M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 121 houders, 29.58M aandelen, $536.67M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 859 aand · $20,573
Officer · 1.52K aand · $36,534
Officer, Director · 6.07K aand · $145,753
Officer · 1.98K aand · $47,536
Officer · 993 aand · $23,852
Officer · 1.36K aand · $32,691
Officer, Director · 31.41K aand · $786,317
Officer · 33.51K aand · $838,805
Officer · 990 aand · $24,750
Officer, Director · 2.20K aand · $54,975
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie